Yetişkinlerde önerilen günlük doz: Günde iki defa birer kapsül veya doktor tavsiyesine göre kullanılır.
Kullanım süresi: Üretim tarihinden itibaren iki yıl.
Çocukların ulaşamayacağı yerde muhafaza edilmelidir.
Ambalaj: 100 mg olan 30 adet kapsül kutuda 10’ar kapsül üç blister.
Literatür:
Katiyar SK; Korman NJ;Mukhtar H;Agarwal R
Department of Dermatologgy,Case Western Reserve
University,Cleveland,OH 44106,USA J Natl Cancer Ins(UNITED STATES)Apr 16 1997,89(8) p 556–66
Journal of Hepatology(Denmark),1997,26/4(871-879)
1.Berkson, B,M(1999).”A conservative triple antioxidant appoach to the treatment of hepatiti C:Combination of alpha lipoic acid(thiocticacid)silymarin,and selenium:theree case histories”Med Klin 94 Suppl 3:84-9
2.Blumenthal Mark; Goldberg Alicia ; Brinckmann, Josef, Eds Tlyler, VarroE, Phd, ScD Herbal Medicine:Expanded Commission E Monographs,American Botanical Council,2000.
3.Blumenthal,Mark;Buse,Werner R;Goldberg,Alicia;Gruenwald,Joerg,PhD; Hall,Tara;Riggins,Chance W.;Rister,Robert S.;Eds,Klein,Sigrid,PhD;Rister,Robert S,Trans,Tyler,VarroE,PhD,ScD,The Complete German Commission E Monographs:Therapeutic Guide to Herbal Medicines.American Botanical Councill,1998.
4.Lapis,K.,a.Jeney,et al.(1986)”Experimental studies on the effect of hepatoprotective compounds”Tokai J Exp Clin Med 11(Suppl):135-45.
5.Mourelle,M,P.Muriel,et al.(1989).”Prevention of CCL4-induced liver cirrhosis by silymarin.”Fundam Clin Pharmacol 3(3):183-91
6.Murray,Michael ,ND;Pizzorno,Joseph,ND.Encyclopedia of Naturel Medicine,Second ed.Prima Publishing,Rocklin.1999
7.Pizorno,Joseph,ND;Murray,Michael T,Eds,Textbook of Natural Medicine,second ed,Churchill Livingstone,1999 Double-Blind Trials
8. Benda ,L.,H.Dittrich,et al.(1980).”(The influence of therapy with silymarin on the survival rate of patietns with liver cirrhosis(author’s trans).”Wien Klin Wochenschr 92(19):678-83.
9. Tanasescu,C.,S.Petrea,et al.(1988).”Use of the Romanian product Silimarina in the treatment of chonıc liver diseases”Med Interne 26(4):311-22 Double-Blind Placebo-Controlled Trials
10.Ferenci,P.,B.Dragosics,et al.(1989).”Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver”J.Hepatol 9(1):105-13..
11.Wellington,K.and B.Jarvis(2001).”Siliymarin:a review of its clinical properties in the management of hepatic disorders.”BioDrugs 15(7):465-89
|
